RHO rs121918354: Understanding the p.Arg135Trp Variant
The rs121918354 variant is a rare genetic change in the RHO gene that results in a p.Arg135Trp amino acid substitution. This specific alteration is associated with autosomal dominant retinitis pigmentosa, a condition characterized by progressive vision loss.
What each genotype means
Typical rhodopsin gene sequence
This genotype represents the common, wild-type sequence for this position in the RHO gene. It is the expected sequence found in the vast majority of the human population.
This is the most common genotype observed globally.
Rare RHO variant carrier
This genotype indicates the presence of the p.Arg135Trp substitution, which is associated with autosomal dominant retinitis pigmentosa. Because this is a rare, pathogenic variant, individuals carrying this genotype should consult with a genetic counselor or ophthalmologist to discuss clinical implications and potential retinal health monitoring.
This genotype is extremely rare, with a global allele frequency reported as less than 0.00001 in population databases.
Rare homozygous RHO variant
This genotype indicates that both copies of the RHO gene carry the p.Arg135Trp substitution. This is an exceptionally rare finding that would likely result in severe, early-onset retinal degeneration; individuals with this result should seek specialized clinical evaluation.
This genotype is not observed in standard population frequency databases due to the extreme rarity of the variant.
What is the rs121918354 Variant?
The rs121918354 variant is a specific genetic change, technically classified as a missense substitution, located within the RHO gene. In this variant, the amino acid arginine is replaced by tryptophan at position 135 of the rhodopsin protein, often denoted as p.Arg135Trp. This change occurs within a critical cytoplasmic loop of the protein, which is essential for the proper signaling of light-sensitive cells in the eye. Because this variant alters the structure of the rhodopsin protein, it can interfere with the normal phototransduction process—the biological mechanism by which the eye converts light into electrical signals for the brain. Geneticists identify this variant by its unique reference SNP ID (rsID), which serves as a standardized label for researchers studying specific locations in the human genome.
The Role of the RHO Gene
The RHO gene provides the instructions for creating the rhodopsin protein, which is found in the rod cells of the retina. Rod cells are the photoreceptors responsible for vision in low-light conditions. When light hits the retina, rhodopsin undergoes a structural change that triggers a cascade of chemical signals, eventually sending visual information to the brain. Because rhodopsin is the primary light-sensing molecule in these cells, its integrity is vital for maintaining healthy vision. Mutations in RHO are well-documented in scientific literature as a leading cause of inherited retinal dystrophies. When the protein is misfolded or dysfunctional due to a genetic variant, it can lead to the premature death of rod cells, which is the hallmark of conditions like retinitis pigmentosa.
Research and Clinical Associations
Scientific research has linked the p.Arg135Trp variant (rs121918354) to autosomal dominant retinitis pigmentosa. In this inheritance pattern, a single copy of the altered gene is sufficient to cause the condition. Studies have identified this variant in families affected by progressive retinal degeneration, where symptoms often begin with night blindness and may progress to peripheral vision loss over time. While the evidence linking this specific variant to the disease is established in clinical contexts, it remains a rare finding. Researchers continue to study how such missense mutations affect protein trafficking and stability within the cell. It is important to note that while this variant is associated with specific clinical outcomes, the severity and progression of retinal conditions can vary significantly between individuals, even among those who share the same genetic change.
Understanding Your Genetic Information
Genetic information regarding variants like rs121918354 is primarily used in clinical settings to help understand the underlying cause of inherited eye conditions. If you or a family member have received results indicating the presence of this variant, it is essential to consult with a genetic counselor or an ophthalmologist who specializes in retinal diseases. These professionals can provide context based on your personal and family medical history. It is important to remember that genetic testing results are not a diagnosis on their own and should be interpreted by a qualified healthcare provider. There is currently no cure for RHO-associated retinitis pigmentosa, but ongoing research is focused on potential therapeutic strategies. Always discuss any concerns about your vision or genetic findings with your clinician before making decisions about your health.
How common is this variant?
The rs121918354 variant is extremely rare, with a global minor allele frequency (MAF) reported in gnomAD as less than 0.00001. It is typically identified as a private or rare familial variant rather than a common polymorphism.
Frequently asked questions
What is RHO-associated retinitis pigmentosa?
RHO-associated retinitis pigmentosa is an inherited eye disorder caused by mutations in the RHO gene. It leads to the progressive loss of rod photoreceptor cells, typically resulting in night blindness followed by a gradual narrowing of the visual field.
Is the rs121918354 variant common?
No, this variant is very rare. It is not found in the general population at high frequencies and is usually identified in specific families affected by retinal disease.
Can I be tested for this variant?
Yes, genetic testing for RHO variants is available through clinical laboratories, often as part of a panel for inherited retinal dystrophies. You should discuss the necessity and implications of such testing with an ophthalmologist or a genetic counselor.
Does having this variant mean I will definitely lose my vision?
While this variant is associated with retinitis pigmentosa, the clinical expression can be variable. You should consult with a retinal specialist to understand the specific prognosis and management options relevant to your clinical presentation.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918354?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RHO
Pathogenic missense variant causing rhodopsin Pro23His substitution that leads to autosomal dominant retinitis pigmentosa and progressive night blindness.
Constitutively active rhodopsin variant (Gly90Asp) causing autosomal dominant congenital stationary night blindness (CSNB).
Encodes the Pro23His (P23H) substitution in rhodopsin, the most common autosomal dominant retinitis pigmentosa allele in North America.
A non-synonymous variant altering rhodopsin protein structure that causes autosomal dominant retinitis pigmentosa with progressive rod photoreceptor loss.
Rhodopsin missense variant (p.Pro23His) responsible for classical autosomal dominant retinitis pigmentosa with rod photoreceptor degeneration.
Classic Pro23His (p.P23H) mutation in rhodopsin causing autosomal dominant retinitis pigmentosa.